Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?

被引：0
|
作者：
Joshua D. Palmer
Deepak Bhamidipati
Andrew Song
Harriet B. Eldredge-Hindy
Joshua Siglin
Tu D. Dan
Colin E. Champ
Isabella Zhang
Voichita Bar-Ad
Lyndon Kim
Jon Glass
James J. Evans
David W. Andrews
Maria Werner-Wasik
Wenyin Shi
机构：
[1] The James Cancer Hospital and Solove Research Institute,Department of Radiation Oncology
[2] Ohio State University Wexner Medical Center,Department of Radiation Oncology
[3] Sidney Kimmel Medical College,Department of Radiation Oncology
[4] Thomas Jefferson University,Department of Radiation Oncology
[5] Sidney Kimmel Cancer Center,Department of Radiation Oncology
[6] Thomas Jefferson University,Department of Radiation Oncology
[7] James Graham Brown Cancer Center,Department of Radiation Medicine
[8] University of Louiville,Department of Neurological Surgery
[9] Hillman Cancer Center at UPMC Altoona,undefined
[10] Harold C Simmons Comprehensive Cancer Center,undefined
[11] University of Texas Southwestern,undefined
[12] UPMC Cancer Center at UPMC St. Margaret,undefined
[13] University of Pittsburgh,undefined
[14] North Shore-Long Island Jewish Medical Center,undefined
[15] Sidney Kimmel Cancer Center,undefined
[16] Thomas Jefferson University,undefined
来源：
Journal of Neuro-Oncology | 2018年 / 140卷
关键词：
Recurrent glioblastoma; Bevacizumab; Re-irradiation; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：623 / 628
页数：5
相关论文
共 50 条
  • [21] Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone
    Arvold, Nils D.
    Shi, Diana D.
    Aizer, Ayal A.
    Norden, Andrew D.
    Reardon, David A.
    Lee, Eudocia Q.
    Nayak, Lakshmi
    Dunn, Ian F.
    Golby, Alexandra J.
    Johnson, Mark D.
    Claus, Elizabeth B.
    Chiocca, E. Antonio
    Ligon, Keith L.
    Wen, Patrick Y.
    Alexander, Brian M.
    JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (03) : 581 - 591
  • [22] Salvage Re-Irradiation for Recurrent High-Grade Glioma and Comparison to Bevacizumab Alone
    Shi, D. D.
    Arvold, N. D.
    Aizer, A. A.
    Norden, A. D.
    Reardon, D. A.
    Lee, E. Q.
    Nayak, L.
    Dunn, I. F.
    Golby, A. J.
    Johnson, M. D.
    Claus, E. B.
    Chiocca, A.
    Ligon, K. L.
    Wen, P.
    Alexander, B. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E107 - E107
  • [23] Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone
    Nils D. Arvold
    Diana D. Shi
    Ayal A. Aizer
    Andrew D. Norden
    David A. Reardon
    Eudocia Q. Lee
    Lakshmi Nayak
    Ian F. Dunn
    Alexandra J. Golby
    Mark D. Johnson
    Elizabeth B. Claus
    E. Antonio Chiocca
    Keith L. Ligon
    Patrick Y. Wen
    Brian M. Alexander
    Journal of Neuro-Oncology, 2017, 135 : 581 - 591
  • [24] Re-Irradiation with high-dose stereotactic radiotherapy for recurrent High-grade Gliomas
    Mousli, A.
    Bocquet, V.
    Frederick, B.
    Louis, C.
    Biver, S.
    Philippi, S.
    Nickers, P.
    Untereiner, M.
    Vogin, G.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S864 - S864
  • [25] Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment
    Wenyin Shi
    Erik S. Blomain
    Joshua Siglin
    Joshua D. Palmer
    Tu Dan
    Yang Wang
    Maria Werner-Wasik
    Jon Glass
    Lyndon Kim
    Voichita Bar Ad
    Deepak Bhamidipati
    James J. Evans
    Kevin Judy
    Christopher J. Farrell
    David W. Andrews
    Journal of Neuro-Oncology, 2018, 137 : 179 - 179
  • [26] Isotoxic and isoeffective stereotactic re-irradiation for high grade gliomas
    Rogers, S.
    Lomax, N.
    Alonso, S.
    Khan, S.
    Rabe, E.
    Meister, A.
    Bodis, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (06) : 584 - 584
  • [27] Proton therapy re-irradiation for large-volume recurrent high-grade gliomas
    Amelio, D.
    Widesott, L.
    Maines, F.
    Fellin, F.
    Righetto, R.
    Vennarini, S.
    Rombi, B.
    Cianchetti, M.
    Dionisi, F.
    Donner, D.
    Rozzanigo, U.
    Schwarz, M.
    Chierichetti, F.
    Galligioni, E.
    Amichetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S543 - S543
  • [28] Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas
    La Rosa, Alonso
    Gutierrez, Alonso N.
    Odia, Yazmin
    McDermott, Michael W.
    Ahluwalia, Manmeet S.
    Mehta, Minesh P.
    Kotecha, Rupesh
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [29] Comparison of risk scores for re-irradiation of patients with recurrent high-grade gliomas (HGG)
    Scholz, H.
    Combs, S. E.
    Kessel, K. A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S470 - S470
  • [30] Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study
    Sahebjam, Solmaz
    Forsyth, Peter A.
    Tran, Nam D.
    Arrington, John A.
    Macaulay, Robert
    Etame, Arnold B.
    Walko, Christine M.
    Boyle, Theresa
    Peguero, Edwin N.
    Jaglal, Michael
    Mokhtari, Sepideh
    Enderling, Heiko
    Raghunand, Natarajan
    Gatewood, Tyra
    Long, Wendy
    Dzierzeski, Jennifer L.
    Evernden, Brittany
    Robinson, Timothy
    Wicklund, Melissa C.
    Kim, Sungjune
    Thompson, Zachary J.
    Chen, Dung-Tsa
    Chinnaiyan, Prakash
    Yu, Hsiang-Hsuan Michael
    NEURO-ONCOLOGY, 2021, 23 (04) : 677 - 686
12345